Whole Body Periodic Acceleration: "Passive Exercise" for Parkinson’s disease

References

• Tucker JM, Welk GJ, Beyler NK. Physical activity in U.S.: adults compliance with the Physical Activity Guidelines for Americans. Am J Prev Med 2011; 40(4):454–461.
   Google Scholar
• Katzel LI, Ivey FM, Sorkin JD et al. Impaired economy of gait and decreased six-minute walk distance in Parkinson′s disease. Parkinsons Dis 2012; 2012:241754.
   Google Scholar
• Nilsson MH, Hariz GM, Iwarsson S et al. Walking ability is a major contributor to fear of falling in people with Parkinson′s disease: implications for rehabilitation. Parkinsons Dis 2012; 2012:713236.
   Google Scholar
• Tan DM, McGinley JL, Danoudis ME et al. Freezing of gait and activity limitations in people with Parkinson′s disease. Arch Phys Med Rehabil 2011; 92(7): 1159–1165.
   Google Scholar
• Adams JA, Bassuk J, Wu D et al. Periodic acceleration: effects on vasoactive, fibrinolytic, and coagulation factors. J Appl Physiol 2005; 98(3):1083–1090.
   Google Scholar
• Sackner MA, Gummels E, Adams JA. Effect of moderate-intensity exercise, whole-body periodic acceleration, and passive cycling on nitric oxide release into circulation. Chest 2005; 128(4):2794–2803.
   Google Scholar
• Uryash A, Bassuk J, Kurlansky P et al. Neurotrophic expression is increased by whole body periodic acceleration (pGz) in mice (Abstract). Circulation 2011; A152.
   Google Scholar
• Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007; 73(2):326–340.
   Google Scholar
• Sackner MA, Gummels E, Adams JA. Nitric oxide is released into circulation with whole-body, periodic acceleration. Chest 2005; 127(1):30–39.
   Google Scholar
• van NM, Speelman AD, Hofman-van Rossum EJ et al. Physical inactivity in Parkinson′s disease. J Neurol 2011; 258(12):2214–2221.
   Google Scholar
• Sato S, Hattori N. Genetic mutations and mitochondrial toxins shed new light on the pathogenesis of Parkinson′s disease. Parkinsons Dis 2011; 2011:979231.
   Google Scholar
• Schapira AH, Jenner P. Etiology and pathogenesis of Parkinson′s disease. Mov Disord 2011; 26(6):1049–1055.
   Google Scholar
• Tansey MG, Goldberg MS. Neuroinflammation in Parkinson′s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010; 37(3):510–518.
   Google Scholar
• Begley S, Yarett I. Can You Build A Better Brain. 2011.
   Google Scholar
• Fumagalli F, Racagni G, Riva MA. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson′s disease. Pharmacogenomics J 2006; 6(2):95–104.
   Google Scholar
• Hallett M. Bradykinesia: why do Parkinson′s patients have it and what trouble does it cause? Mov Disord 2011; 26(9): 1579–1581.
   Google Scholar
• Xia R, Powell D, Rymer WZ et al. Differentiation between the contributions of shortening reaction and stretch-induced inhibition to rigidity in Parkinson′s disease. Exp Brain Res 2011; 209(4):609–618.
   Google Scholar
• Corcos DM, Chen CM, Quinn NP et al. Strength in Parkinson′s disease: relationship to rate of force generation and clinical statusAnn Neurol 1996; 39(1):79–88.
   Google Scholar
• Gdynia HJ, Sperfeld AD, Unrath A et al. Histopathological analysis of skeletal muscle in patients with Parkinson′s disease and ′dropped head′/′bent spine′ syndrome. Parkinsonism Relat Disord 2009; 15(9):633–639.
   Google Scholar
• Abou-Sleiman PM, Healy DG, Wood NW. Causes of Parkinson′s disease: genetics of DJ-1. Cell Tissue Res 2004; 318(1):185–188.
   Google Scholar
• Rosen KM, Veereshwarayya V, Moussa CE et al. Parkin protects against mitochondrial toxins and betaamyloid accumulation in skeletal muscle cells.J Biol Chem 2006; 281(18):12809–12816.
   Google Scholar
• von CR, Dawson VL, Dawson TM. Parkin-associated Parkinson′s disease. Cell Tissue Res 2004; 318(1):175–184.
   Google Scholar
• Shtifman A, Zhong N, Lopez JR et al. Altered Ca2+ homeostasis in the skeletal muscle of DJ-1 null mice. Neurobiol Aging 2011; 32(1):125–132.
   Google Scholar
• Takahashi S, Nakashima Y. Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. Br J Nutr 2012; 107(6):774–780.
   Google Scholar
• Wu H, Jin Y, Arias J et al. In vivo upregulation of nitric oxide synthases in healthy rats. Nitric Oxide 2009; 21(1):63–68.
   Google Scholar
• Lopez JR, Mosquera J, Mijares A et al. Eccentric exercise elicits elevation of [Ca2+]rest in skeletal muscle. Periodic acceleration enhanced the recovery (Abstract). Biophysical Society 2012.
   Google Scholar
• Ford B. Pain in Parkinson′s disease. Mov Disord 2010; 25 Suppl 1:S98–103.
   Google Scholar
• Lieberman A. Depression in Parkinson′s disease -- a review. Acta Neurol Scand 2006; 113(1):1–8.
   Google Scholar
• Moore PK, Marshall M. Nitric oxide releasing acetaminophen (nitroacetaminophen). Dig Liver Dis 2003; 35 Suppl 2:S49–S60.
   Google Scholar
• Ricci V, Pomponi M, Martinotti G et al. Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients. J Clin Psychopharmacol 2010; 30(6):751–753.
   Google Scholar
• van NM, Speelman AD, Hofman-van Rossum EJ et al. Physical inactivity in Parkinson′s disease. J Neurol 2011; 258(12): 2214–2221.
   Google Scholar
• Rokutanda T, Izumiya Y, Miura M et al. Passive exercise using Whole-Body Periodic Acceleration enhances blood Supply to ischemic hindlimb. Arterioscler. Throm. Vasc. Biol. 2011; 31(12): 28722880.
   Google Scholar
• Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 2011; 77(3):288–294.
   Google Scholar
• Rasmussen P, Brassard P, Adser H et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 2009; 94(10):1062–1069.
   Google Scholar
• Speelman AD, van de Warrenburg BP, van NM et al. How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol 2011; 7(9):528–534.
   Google Scholar
• Chou KL. Adverse events from the treatment of Parkinson′s disease. Neurol Clin 2008; 26(3 Suppl):S65–83,vi.
   Google Scholar